LTC3207941I2 - - Google Patents

Info

Publication number: LTC3207941I2
Authority: LT; Lithuania

Application number

LTPA2021507C

Original Assignee

Scott & White Memorial Hospital

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-09-07

Filing date

2021-05-12

Publication date

2022-10-10

2021-05-12 Application filed by Scott & White Memorial Hospital filed Critical Scott & White Memorial Hospital

2021-06-10 Publication of LTPA2021507I1 publication Critical patent/LTPA2021507I1/lt

2022-10-10 Publication of LTC3207941I2 publication Critical patent/LTC3207941I2/lt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5403—IL-3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/202—IL-3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/642—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Developmental Biology & Embryology (AREA)
Cell Biology (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Virology (AREA)
Toxicology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

LTPA2021507C 2006-09-07 2021-05-12 LTC3207941I2 (lt)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US84347106P	2006-09-07	2006-09-07
US93277207P	2007-06-01	2007-06-01
EP07837840.3A EP2063907B1 (en)	2006-09-07	2007-09-07	Methods and compositions based on diphtheria toxin-interleukin-3 conjugates
PCT/US2007/019481 WO2008030539A2 (en)	2006-09-07	2007-09-07	Methods and compositions based on diphtheria toxin-interleukin-3 conjugates

Publications (2)

Publication Number	Publication Date
LTPA2021507I1 LTPA2021507I1 (lt)	2021-06-10
LTC3207941I2 true LTC3207941I2 (lt)	2022-10-10

Family

ID=39157851

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
LTEP17151480.5T LT3207941T (lt)	2006-09-07	2007-09-07	Būdai ir kompozicijos difterijos toksino ir interleukino 3 konjugatų pagrindu
LTPA2021507C LTC3207941I2 (lt)	2006-09-07	2021-05-12

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
LTEP17151480.5T LT3207941T (lt)	2006-09-07	2007-09-07	Būdai ir kompozicijos difterijos toksino ir interleukino 3 konjugatų pagrindu

Country Status (17)

Country	Link
US (7)	US7763242B2 (lt)
EP (4)	EP2063907B1 (lt)
JP (7)	JP5550905B2 (lt)
AU (1)	AU2007293047B2 (lt)
CA (5)	CA2923381A1 (lt)
CY (3)	CY1119654T1 (lt)
DK (2)	DK3207941T6 (lt)
ES (3)	ES2646545T3 (lt)
FR (1)	FR21C1017I2 (lt)
HU (2)	HUE048356T2 (lt)
LT (2)	LT3207941T (lt)
LU (1)	LUC00206I2 (lt)
NL (1)	NL301103I2 (lt)
PL (2)	PL3207941T6 (lt)
PT (1)	PT3207941T (lt)
SI (1)	SI3207941T1 (lt)
WO (1)	WO2008030539A2 (lt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5095216B2 (ja)	2003-11-14	2012-12-12	ローラスセラピューティクスインコーポレーテッド	アリールイミダゾールおよびその抗癌剤としての使用
JP5550905B2 (ja)	2006-09-07	2014-07-16	スコットアンドホワイトヘルスケア	ジフテリア毒素−インターロイキン−３コンジュゲートに基づく方法及び組成物
WO2010027802A2 (en)	2008-08-25	2010-03-11	New York University	Methods for treating diabetic wounds
US20110171219A1 (en) *	2008-09-19	2011-07-14	Fahar Merchant	Treating cancer stem cells using targeted cargo proteins
JP6018507B2 (ja) *	2010-02-17	2016-11-02	シーエスエル、リミテッド	Ｉ型インターフェロン産生細胞を標的化するための組成物及び方法
WO2011160082A2 (en)	2010-06-17	2011-12-22	New York University	Therapeutic and cosmetic uses and applications of calreticulin
WO2012019061A2 (en)	2010-08-05	2012-02-09	Stem Centrx, Inc.	Novel effectors and methods of use
US20130224191A1 (en)	2010-08-27	2013-08-29	Robert A. Stull	Notum protein modulators and methods of use
CN106620693A (zh)	2010-09-03	2017-05-10	艾伯维施特姆森特克斯有限责任公司	新型调节剂及使用方法
AU2011338425A1 (en)	2010-12-08	2013-05-02	Stemcentrx, Inc.	Novel modulators and methods of use
SA112330278B1 (ar)	2011-02-18	2015-10-09	ستيم سينتركس، انك.	مواد ضابطة جديدة وطرق للاستخدام
ES2656050T3 (es)	2011-07-06	2018-02-22	Glaxosmithkline Biologicals Sa	Composiciones de combinación inmunogénica y usos de las mismas
US20130058947A1 (en)	2011-09-02	2013-03-07	Stem Centrx, Inc	Novel Modulators and Methods of Use
EP3093294A1 (en)	2012-02-24	2016-11-16	Stemcentrx, Inc.	Dll3 modulators and methods of use
PE20150091A1 (es)	2012-02-24	2015-02-16	Stem Centrx Inc	Anticuerpos anti-sez6 y metodos de empleo
SMT201900339T1 (it)	2013-02-22	2019-07-11	Medimmune Ltd	Coniugati anticorpo anti-dll3/pbd e loro usi
WO2015031698A1 (en)	2013-08-28	2015-03-05	Stem Centrx, Inc.	Site-specific antibody conjugation methods and compositions
CA2922529A1 (en)	2013-08-28	2015-03-05	Stemcentrx, Inc.	Novel sez6 modulators and methods of use
DK3052102T3 (da) *	2013-10-04	2020-03-09	Aptose Biosciences Inc	Sammensætninger til behandling af cancere
US10053511B2 (en)	2013-11-06	2018-08-21	Abbvie Stemcentrx Llc	Anti-claudin antibodies and methods of use
MX2016007369A (es)	2013-12-12	2016-09-08	Stemcentrx Inc	Nuevos anticuerpos anti-dpep3 y metodos de uso.
KR20170008202A (ko)	2014-02-21	2017-01-23	애브비 스템센트알엑스 엘엘씨	흑색종에 사용하기 위한 항-ｄｌｌ3 항체 및 약물 접합체
EP3711780A3 (en)	2014-04-30	2020-12-09	Pfizer Inc	Anti-ptk7 antibody-drug conjugates
TW201617368A (zh)	2014-09-05	2016-05-16	史坦森特瑞斯公司	新穎抗ｍｆｉ２抗體及使用方法
AU2017254674A1 (en)	2016-04-21	2018-11-01	Abbvie Stemcentrx Llc	Novel anti-BMPR1B antibodies and methods of use
CN107793481A (zh) *	2016-08-31	2018-03-13	南京传奇生物科技有限公司	一种靶向人cd123的嵌合受体配体及其应用
CN111417395A (zh)	2017-10-30	2020-07-14	艾普托斯生物科学公司	用于治疗癌症的芳基咪唑
EP3784270A1 (en)	2018-04-27	2021-03-03	Stemline Therapeutics Inc.	Methods of treating an autoimmune disease with a human interleukin-3 (il-3)-diphtheria toxin conjugate (dt-il3)
EP3802834A4 (en) *	2018-05-30	2022-08-03	The Governing Council of the University of Toronto	METHODS AND KITS FOR IDENTIFYING A PROTEIN RELATED TO RECEPTOR-LIGAND INTERACTIONS
CN113329752A (zh)	2018-10-31	2021-08-31	斯坦林治疗公司	用白喉毒素-人白细胞介素-3缀合物与其它药剂组合治疗骨髓增生性肿瘤的组合治疗方法
WO2020112642A1 (en)	2018-11-30	2020-06-04	Stemline Therapeutics, Inc.	Improved methods of treating myeloproliferative neoplasms with a diphtheria toxin-human interleukin-3 conjugate
EP4061967A1 (en) *	2019-11-21	2022-09-28	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods and compositions for diagnosing and treating chronic myelomonocytic leukemia (cmml)
CA3204584A1 (en)	2020-12-10	2022-06-16	Stemline Therapeutics, Inc.	Improved lyophilized formulation

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1983003971A1 (en)	1982-05-12	1983-11-24	President And Fellows Of Harvard College	Hybrid proteins
US5080898A (en)	1982-05-12	1992-01-14	The University Hospital	Enzymatically active toxin coupled to a cell-specific ligand
US5668255A (en)	1984-06-07	1997-09-16	Seragen, Inc.	Hybrid molecules having translocation region and cell-binding region
US6022950A (en)	1984-06-07	2000-02-08	Seragen, Inc.	Hybrid molecules having translocation region and cell-binding region
US5128326A (en)	1984-12-06	1992-07-07	Biomatrix, Inc.	Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
GB8628068D0 (en)	1986-11-24	1986-12-31	Unilever Plc	Aqueous gel comprising carrageenan
AU642932B2 (en)	1989-11-06	1993-11-04	Alkermes Controlled Therapeutics, Inc.	Protein microspheres and methods of using them
EP0517829B2 (en)	1990-03-02	2007-12-26	Boston Medical Center Corporation	Improved chimeric toxins
US5698155A (en)	1991-05-31	1997-12-16	Gs Technologies, Inc.	Method for the manufacture of pharmaceutical cellulose capsules
DE4121547A1 (de)	1991-06-28	1993-01-14	Daimler Benz Ag	Mehrschichtisolierfolie
US6162432A (en)	1991-10-07	2000-12-19	Biogen, Inc.	Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
DE4140121C2 (de)	1991-12-05	1994-06-30	Manfred Mueller	Verfahren zum Herstellen von gefaßten, gegossenen Schmuckstücken
US5912015A (en)	1992-03-12	1999-06-15	Alkermes Controlled Therapeutics, Inc.	Modulated release from biocompatible polymers
US5441050A (en)	1992-12-18	1995-08-15	Neoprobe Corporation	Radiation responsive surgical instrument
AU5965296A (en) *	1995-05-31	1996-12-18	Regents Of The University Of Minnesota	Recombinant polypeptide cytotoxins for cancer treatment
EP0850051A2 (en)	1995-08-31	1998-07-01	Alkermes Controlled Therapeutics, Inc.	Composition for sustained release of an agent
US5843633A (en)	1996-04-26	1998-12-01	Amcell Corporation	Characterization of a human hematopoietic progenitor cell antigen
US20040013664A1 (en)	1997-01-14	2004-01-22	Gentz Reiner L.	Tumor necrosis factor receptors 6 alpha & 6 beta
US6004528A (en)	1997-09-18	1999-12-21	Bergstein; Ivan	Methods of cancer diagnosis and therapy targeted against the cancer stemline
US7361336B1 (en)	1997-09-18	2008-04-22	Ivan Bergstein	Methods of cancer therapy targeted against a cancer stem line
US5989463A (en)	1997-09-24	1999-11-23	Alkermes Controlled Therapeutics, Inc.	Methods for fabricating polymer-based controlled release devices
SE512663C2 (sv)	1997-10-23	2000-04-17	Biogram Ab	Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
US7030228B1 (en)	1999-11-15	2006-04-18	Miltenyi Biotec Gmbh	Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
CA2393132A1 (en)	1999-12-03	2001-06-07	The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland	Dendritic cell-specific antibodies
AU2001250030B2 (en)	2000-03-06	2004-11-25	University Of Kentucky Research Foundation	Use of a compound that selectively binds to CD123 to impair hematologic cancer progenitor cell
WO2002070007A1 (en)	2001-03-02	2002-09-12	Medimmune, Inc.	Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists
AU2002322478A1 (en)	2001-03-02	2002-12-16	Medimmune, Inc.	Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
WO2004091510A2 (en)	2003-04-11	2004-10-28	Medimmune, Inc.	Recombinant il-9 antibodies and uses thereof
JP5550905B2 (ja) *	2006-09-07	2014-07-16	スコットアンドホワイトヘルスケア	ジフテリア毒素−インターロイキン−３コンジュゲートに基づく方法及び組成物
AU2014201901B2 (en)	2006-09-07	2016-05-05	Scott & White Healthcare	Methods and compositions based on diphtheria toxin-interleukin-3 conjugates
US8163279B2 (en)	2007-04-13	2012-04-24	Stemline Therapeutics, Inc.	IL3Rα antibody conjugates and uses thereof
FR2982762B1 (fr)	2011-11-21	2014-12-12	Patrick Arnoux	Appareil de brossage de dents a multiples systemes rotatifs de brossage
CN104245720A (zh)	2012-02-29	2014-12-24	Ambrx公司	白细胞介素-3多肽结合物和其用途
WO2021044497A1 (ja)	2019-09-02	2021-03-11	日本電信電話株式会社	データ分析処理装置、データ分析処理方法及びデータ分析処理プログラム

2007
- 2007-09-07 JP JP2009527415A patent/JP5550905B2/ja active Active
- 2007-09-07 ES ES07837840.3T patent/ES2646545T3/es active Active
- 2007-09-07 CA CA2923381A patent/CA2923381A1/en not_active Abandoned
- 2007-09-07 PL PL17151480T patent/PL3207941T6/pl unknown
- 2007-09-07 ES ES19159793T patent/ES2987072T3/es active Active
- 2007-09-07 HU HUE17151480A patent/HUE048356T2/hu unknown
- 2007-09-07 EP EP07837840.3A patent/EP2063907B1/en active Active
- 2007-09-07 PL PL07837840T patent/PL2063907T3/pl unknown
- 2007-09-07 DK DK17151480.5T patent/DK3207941T6/da active
- 2007-09-07 CA CA3007075A patent/CA3007075C/en active Active
- 2007-09-07 LT LTEP17151480.5T patent/LT3207941T/lt unknown
- 2007-09-07 US US11/899,747 patent/US7763242B2/en active Active
- 2007-09-07 ES ES17151480T patent/ES2781402T7/es active Active
- 2007-09-07 PT PT171514805T patent/PT3207941T/pt unknown
- 2007-09-07 DK DK07837840.3T patent/DK2063907T3/da active
- 2007-09-07 CA CA3053981A patent/CA3053981C/en active Active
- 2007-09-07 CA CA3153438A patent/CA3153438C/en active Active
- 2007-09-07 WO PCT/US2007/019481 patent/WO2008030539A2/en not_active Ceased
- 2007-09-07 EP EP24155503.6A patent/EP4414036A3/en active Pending
- 2007-09-07 AU AU2007293047A patent/AU2007293047B2/en active Active
- 2007-09-07 EP EP17151480.5A patent/EP3207941B3/en active Active
- 2007-09-07 EP EP19159793.9A patent/EP3520806B1/en active Active
- 2007-09-07 CA CA2698595A patent/CA2698595C/en active Active
- 2007-09-07 SI SI200732148T patent/SI3207941T1/sl unknown
2009
- 2009-02-09 US US12/368,048 patent/US8470307B2/en active Active
2013
- 2013-05-17 US US13/896,923 patent/US9181317B2/en active Active
2014
- 2014-04-01 JP JP2014075847A patent/JP5902223B2/ja active Active
2015
- 2015-07-17 US US14/802,398 patent/US9631006B2/en active Active
2016
- 2016-03-09 JP JP2016045210A patent/JP6336500B2/ja active Active
2017
- 2017-03-10 US US15/455,420 patent/US10259853B2/en active Active
- 2017-11-03 CY CY20171101153T patent/CY1119654T1/el unknown
2018
- 2018-05-02 JP JP2018088719A patent/JP6654660B2/ja active Active
2019
- 2019-02-08 US US16/271,456 patent/US11130792B2/en active Active
2020
- 2020-01-30 JP JP2020013230A patent/JP2020079260A/ja active Pending
- 2020-03-23 CY CY20201100271T patent/CY1123035T1/el unknown
2021
- 2021-04-22 HU HUS2100013C patent/HUS2100013I1/hu unknown
- 2021-04-22 CY CY2021011C patent/CY2021011I2/el unknown
- 2021-05-11 FR FR21C1017C patent/FR21C1017I2/fr active Active
- 2021-05-12 NL NL301103C patent/NL301103I2/nl unknown
- 2021-05-12 LU LU00206C patent/LUC00206I2/en unknown
- 2021-05-12 LT LTPA2021507C patent/LTC3207941I2/lt unknown
- 2021-08-25 US US17/411,947 patent/US12180257B2/en active Active
2022
- 2022-02-15 JP JP2022020917A patent/JP2022065089A/ja active Pending
2024
- 2024-04-04 JP JP2024060550A patent/JP2024088720A/ja active Pending

Also Published As

Publication number	Publication date
US20190169251A1 (en)	2019-06-06
US9631006B2 (en)	2017-04-25
CA2698595A1 (en)	2008-03-13
EP3520806A1 (en)	2019-08-07
EP2063907A2 (en)	2009-06-03
CY1123035T1 (el)	2021-09-14
CA3053981A1 (en)	2008-03-13
PL2063907T3 (pl)	2018-06-29
WO2008030539A2 (en)	2008-03-13
EP3520806B1 (en)	2024-03-20
US20130315860A1 (en)	2013-11-28
LUC00206I2 (lt)	2022-10-07
DK3207941T6 (da)	2020-11-09
CA3007075C (en)	2019-10-15
EP2063907A4 (en)	2011-08-31
ES2781402T3 (es)	2020-09-01
LTPA2021507I1 (lt)	2021-06-10
WO2008030539A3 (en)	2009-04-09
US10259853B2 (en)	2019-04-16
US20160024167A1 (en)	2016-01-28
DK2063907T3 (da)	2017-11-13
ES2987072T3 (es)	2024-11-13
PL3207941T3 (pl)	2020-07-27
EP3207941B1 (en)	2019-12-25
CA2923381A1 (en)	2008-03-13
ES2646545T3 (es)	2017-12-14
CY1119654T1 (el)	2019-07-10
JP2016155830A (ja)	2016-09-01
EP3207941A1 (en)	2017-08-23
US9181317B2 (en)	2015-11-10
JP6336500B2 (ja)	2018-06-06
CY2021011I1 (el)	2021-10-15
JP2010502712A (ja)	2010-01-28
CA2698595C (en)	2016-07-26
FR21C1017I1 (lt)	2021-07-02
HUE048356T2 (hu)	2020-07-28
JP5902223B2 (ja)	2016-04-13
CA3053981C (en)	2022-07-12
EP4414036A3 (en)	2024-10-09
NL301103I2 (nl)	2021-08-02
JP2022065089A (ja)	2022-04-26
HUS2100013I1 (hu)	2021-05-28
JP2018135378A (ja)	2018-08-30
US8470307B2 (en)	2013-06-25
EP2063907B1 (en)	2017-08-09
US20080138313A1 (en)	2008-06-12
EP3207941B3 (en)	2020-08-19
EP4414036A2 (en)	2024-08-14
DK3207941T3 (da)	2020-03-30
CY2021011I2 (el)	2021-10-15
US11130792B2 (en)	2021-09-28
CA3153438A1 (en)	2008-03-13
US20220235108A1 (en)	2022-07-28
JP2014144967A (ja)	2014-08-14
JP2020079260A (ja)	2020-05-28
ES2781402T7 (es)	2021-06-09
JP5550905B2 (ja)	2014-07-16
LT3207941T (lt)	2020-04-10
PT3207941T (pt)	2020-04-02
JP6654660B2 (ja)	2020-02-26
US20180022788A1 (en)	2018-01-25
PL3207941T6 (pl)	2020-11-16
FR21C1017I2 (fr)	2022-04-22
SI3207941T1 (sl)	2020-08-31
NL301103I1 (nl)	2021-06-17
US20090232767A1 (en)	2009-09-17
JP2024088720A (ja)	2024-07-02
US7763242B2 (en)	2010-07-27
AU2007293047A1 (en)	2008-03-13
CA3007075A1 (en)	2008-03-13
AU2007293047B2 (en)	2014-01-09
US12180257B2 (en)	2024-12-31
CA3153438C (en)	2024-03-12

Publication	Publication Date	Title
LTC3207941I2 (lt)	2022-10-10
BE2015C016I2 (lt)	2025-12-10
BRPI0720064A2 (lt)	2017-08-15
BRMU8603216U8 (lt)	2012-10-16
BRPI0715824A8 (lt)	2008-02-28
BRPI0713487A2 (lt)	2012-11-13
BR122016023444A2 (lt)	2008-01-15
BRPI0708307B8 (lt)	2021-05-25
AT504380A8 (lt)	2008-12-15
CN300728147S (zh)	2008-01-02	管连接器的阴壳体
CN300729839S (zh)	2008-01-09	汽车后侧围内蒙皮(e)
CN300725933S (zh)	2008-01-02	童装(3831)
CN300729367S (zh)	2008-01-09	油桶
CN300729264S (zh)	2008-01-09	螺钉旋具手柄(h0128d)
CN300729548S (zh)	2008-01-09	包装袋(快乐ok脆草莓味威化饼干)
CN300728951S (zh)	2008-01-09	更衣柜(组合式6)
CN300728516S (zh)	2008-01-09	一次性尿裤
CN300728492S (zh)	2008-01-02	宠物用品(葡萄)
CN300729721S (zh)	2008-01-09	钧瓷(海棠洗)
CN300725934S (zh)	2008-01-02	童装(3833)
CN300728338S (zh)	2008-01-02	门(12)
CN300728277S (zh)	2008-01-02	地暖专用隔热板(3)
CN300728230S (zh)	2008-01-02	吸油烟机(十三)
CN300725927S (zh)	2008-01-02	童装(3795)
CN300728041S (zh)	2008-01-02	玩具(7)